Back to search

Peptide record

TPDB21830

Antibacterial Antifungal Hemolysis Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB21830
Antibacterial Antifungal Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia CAFPdb dbAMP PD_Hemolysis
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Antifungal, Hemolysis, and other sources) peptide sequence curated from Peptipedia, CAFPdb, dbAMP, and other sources, with an available 3D structural model.
Sequence
KIGKWLLWKGIKKIGKWL
Physicochemical Analysis
C111H179N27O19
ARNDCEQHMFPSTYV
K
2195.81
11.21
6
0
9
+6
-2.19
-0.133
130.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
16500
751.43
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
3
G
0
H
3
I
3
L
6
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 3 L: 3 K: 6 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 0
Chemical Descriptors
18
C111H179N27O19
2195.81
11.21
+6
-2.19
-0.133
Evidence Records 7 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
2.69 µM
Hemolytic Cytotoxic
10% Hemolysis | 2.69 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 2 Activity

Activity

100% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
100% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 3 Activity

Activity

62% Killing
Toxicity
8 µM
Cytotoxic
62% Killing | 8 | µM | target cell: Intestinal Porcine Epithelial Cells IPEC-J2

Target

Intestinal Porcine Epithelial Cells IPEC-J2

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 4 Activity

Activity

92% Killing
Toxicity
64 µM
Cytotoxic
92% Killing | 64 | µM | target cell: Intestinal Porcine Epithelial Cells IPEC-J2

Target

Intestinal Porcine Epithelial Cells IPEC-J2

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 5 Activity

Activity

43% Killing
Toxicity
8 µM
Cytotoxic
43% Killing | 8 | µM | target cell: Porcine mammary epithelial cells PMEC

Target

Porcine mammary epithelial cells PMEC

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 6 Activity

Activity

90% Killing
Toxicity
64 µM
Cytotoxic
90% Killing | 64 | µM | target cell: Porcine mammary epithelial cells PMEC

Target

Porcine mammary epithelial cells PMEC

Source & Reference

NA
DBAASP
A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates. | Front Microbiol | 2020
Evidence 7 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis